The Adult Stem Cell Therapy & Regenerative Medicine conference runs through Wednesday in Cleveland. “One can take, in principle, bone marrow from someone, correct the sickle cell mutation, transplant it back into people, and they should be cured of sickle cell disease,” says Conlon.Ĭonlon says the new CRISPR/cas technology is a faster, cheaper, and more reliable way to do gene splicing for research and potentially in clinical settings - “People are taking this technology and finding new and creative uses for it that no one has yet conceived of.” Conlan practiced at a regional defense litigation firm representing employers across Pennsylvania in the area of workers compensation law and matters of. Ronald is registered to vote in Franklin County, Ohio. He says it could lead to new ways to treat diseases like sickle cell anemia and AIDS. Ronald James Conlon (age 82) is listed at 734 Hunt Valley Dr Reynoldsburg, Oh 43068 and has no known political party affiliation. The location you tried did not return a result. Search doctors, conditions, or procedures. So it’s a huge revolution for scientists.”Ĭonlon says CRISPR/cas is a type of DNA scissors that can custom cut and replace any gene quickly and reliably. See Reviews & Make an Appointment LIST YOUR PRACTICE Dentist Hospital Pharmacy Search. Conlon has practiced orthodontics in McHenry since 1977.

Conlon is an American Board Certified Specialist in orthodontics. 1977) at the University of Illinois Medical Center in Chicago. 1975) and both his specialty training and Master’s Degree in Orthodontics (M.S. 'It has made understanding what genes do and what mutations do in model organisms that much easier. Conlon received his Dental Degree (D.D.S. “It is an immensely powerful tool,' says Conlon. As director of the Case Transgenic and Targeting Facility, Case Western Reserve University’s Ronald Conlon alters genes in mice so scientists can use them to test stem cell and other therapies.īut he says radical new gene splicing technology called CRISPR/cas is opening up a new era in research and therapy.

Dr. ronald conlon